ArticlePregnancy (Hoboken, N.J.)2025
Sociodemographic barriers to continuous glucose monitoring among pregnancies with type 1 diabetes.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Continuous glucose monitor (CGM) use is associated with improved glycemic management among pregnant patients with type 1 diabetes. Individual- and neighborhood-level social determinants of health (SDHs) are associated with low CGM use and adverse pregnancy outcomes. We hypothesized that SDHs are associated with decreased CGM use in pregnancy among patients with type 1 diabetes. Methods: We evaluated a cohort of pregnancies receiving type 1 diabetes and delivery care at a single large health system from 2016 to 2023. Patients were evaluated by public payor status. The primary outcome was CGM use. Additional SDH characteristics evaluated included home Area Deprivation Index (ADI) percentile and rurality status. Regression analyses generating models predicting CGM use included age, baseline body mass index (BMI), diabetes duration, and delivery year. Results: Among 288 pregnancies with type 1 diabetes, 144 (50.0%) had public insurance. Public payor was associated with younger age and shorter diabetes duration, and those patients were more commonly nulliparous and Black. Controlling for baseline characteristics, CGM uptake was lower among the public insured (38.9% vs. 61.8%; adjusted odds ratio [aOR], 0.39; 95% confidence interval [CI], 0.23-0.66). Over time, uptake increased, though publicly insured patients lagged by two years. Evaluating SDH characteristics and CGM usage over time, public insurance (aOR, 0.47; 95% CI, 0.24-0.91) and ADI (aOR, 0.96; 95% CI, 0.95-0.98) were associated with CGM use; rurality was not. Conclusion: Public insurance and high neighborhood deprivation are risk factors for lower CGM uptake, potentially representing an indirect and targetable mechanism by which SDH impacts glycemic management for pregnancies with type 1 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.